ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
FDA grants accelerated approval to amivantamab/hyaluronidase for recurrent/metastatic HNSCC after platinum and PD-1/PD-L1 therapy, based on 42% ORR.
Read More
FDA grants accelerated approval to Rybrevant Faspro for adults with recurrent or metastatic head and neck squamous cell carcinoma.
Read More
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
Read More
The U.S. HHS awarded $247.9 million in grants to expand mental health and addiction treatment services nationwide.
Read More
A Doctors Without Borders worker infected with Bundibugyo virus during DRC Ebola outbreak was evacuated to the Netherlands for specialized treatment.
Read More
The FDA authorized emergency use of Capstar and generic Nitenpyram to prevent and treat New World screwworm in dogs and cats nationwide.
Read More
The FDA approved Zanvastro, the first drug to treat Alexander disease by targeting abnormal GFAP buildup in pediatric and adult patients.
Read More
CDC and state officials investigated a 2013 multistate Listeria outbreak linked to Crave Brothers soft-ripened cheeses sold at Whole Foods, leading to a recall.
Read More
The FDA approved Roivant’s Lisraya (brepocitinib), the first oral dual TYK2/JAK1 inhibitor, to treat dermatomyositis in adults.
Read More
GURU INC. recalled Infla-650 herbal supplement after FDA found undeclared drugs acetaminophen, diclofenac, and phenylbutazone in the capsules.
Read More